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Rctinoic acid (RA) and triiodothyronine (T,) exert many of their actions by binding to specific nuclear eceptors (respectively, RA receptor (RAR) 
and T,) receptor (TR) belonging to a ‘superfamily of receptors. Some hetcrologous regulation of those receptors has been shown, and in particular 
regulation of the maximum binding capacity of TR by either ctinol or RA. Now, using hyprthyroidic rats as a model, the effect of RA on binding 
capacity and on the mRNA levels of TR and RAR wits investigated. The resulls show that the benefit of vitamin A treatment for the hyprthyroidic 
state, w/hi& has been described for a long time, could be the result of a down.heteroregulation f TR by RA, the active metabolite of rcdnol. 
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1. INTRODUCTION 
Retinoic acid (RA) and triiodothyronine (T3) have 
been known for a long time to exert profound effects on 
development and differentiation. Many of the diverse 
cellular responses that these agents elicit are initiated by 
their binding to specific nuclear receptors, and result 
from the induction of the transcription of several genes 
[l], Structural homologies among these receptors have 
led to considering them as belonging to a ‘superfamily’ 
of DNA binding proteins [2]. Moreover, it was shown 
that these receptors can be regulated by their own li- 
gands (homologous regulation) [3] and in some cases by 
ligands that are not their own (heterologous regulation) 
[4-63. Wirh respect o RA and T3, in euthyroidic rats or 
control cells it was predicted that retinol or retinoic acid 
could down-modulate the nuclear Tj receptor (TR) and 
its messenger (c-erb A mRNA) [7,8]. These findings 
prompted us to examine, in rats made hyperthyroidic, 
the effects of RA on the properties of both its own 
receptor (RAR) as well as TR, and also on the level of 
their respective mRNA (RAR mRNA and c-erb A 
mRNA). 
2. MATERIALS AND METHODS 
2.1. Experitnental onitnah 
Pathogen-free male Wistar rats (w?iBht range 180-200 g) were ob- 
tained from IFFA-CREDO (L’Arbresle, France). The animals were 
segregated into three groups of eight animals. 
‘p , J CXi! Ri! 2CG:Cd r&s. A!?...... _im+ were injected (R! 18.00 h) intrapcm 
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ritoneally with 50 yg of T, (Sigma, no. 2752) in 0.01 N NrlOH/lOO g 
b.wt. per dzy for 3 days. and the third day they also rcceivld 500~6 
of all-rrans-RA (Sigma, no. 2625) in arachis oil/l00 g b.wt. by gastric 
intubation. They were killed I2 h after RA was administered and 
samples of liver tissue were collected for analysis. 
T’, treutmm. Animals were administered with T, as described above 
and then received rirachis oil only. 
Cormof mimafs. Kats rcccivcd the vehicles only. 
2.2, Properties of mrclear receptors 
2.2. I. Receptors preparation 
Nuclei were obtained as described by De Groot ct al. IQ]. TRs were 
obtained 3s described by Torrcsani et al. [IO]. To obtain RAR, the 
nuclei were washed three times with binding buffer (IO mM HEPES, 
1.5 mM MgQ, 10 mM KCI, pH 7.9) and then submitted to a DNAsc 
I (Sigtni no, D 4527) digestion for 30 min at room lcmpcmture. 
followed by a high salt extraction (0.5 NaCI). The nuclczr extract was 
then obtained by centrifugation [12]. Protein content of the nuclear 
extracts was determined using the Bradford assay [I I], 
2.22 Binding stud& 
TR binding was performed according to Torresani et al. IlO]. RAR 
binding was modilied from Daly et al. [12]. Aliquots of nuclear extract 
(961~1) weremixed with4/.dofincreasingconccntr~tions(O.I5-I.T~M 
in dimethyl-sulfoxide) of pi-ijretinoic acid (52.5 Ciimmol; NEN Du- 
pont de Nemours, Paris, France). After I h incubation al 4% 50~1 
of the hlcubation mixture was submitted lo high-prformmI@Z size- 
exclusion chromatography separation on R TSK gel G3COOSW column 
(300 x 7.5 mm TosoHaas), and cluted with 0.3 M KHJQ, pH 7.8, 
at a flow rate of 0.5 ml/min. The column WBS standardized with a 
mixture of human albumin (67 kDa), egg albumin (45 kDa), and horse 
myoglobin (16.8 kDa). Fractions of0.2 ml were collected and counted 
in a liquid scintillation counter using Ready Value Cocktail (Beckman) 
as the scintillation liquid. Radioactive counts obtained in frdclicns 
containing the RAR-[‘HjRA complex were added and expressed ii5 
picamoles of bound ligand pr mg of proteins. Non specilic binding 
was determined by incubation in Lhe presence oi 1060.fold ticcss d 
unlabellcd RA (Fig. I). Scatchard analysis wns then performed. 
2.3. Qumttjfiratiorr o/mRNAs 
The absolute values of c-erb-A and RAR mRNAs aumol bc dctcr- 
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mined directly, but a proportion can be deduced by comparing them 
with thc/$actin internal standard simultaneously reverse transcribed 
and umplified in the silme test tube. 
Exracrion oJRNA was performed according to Sambrookct al. [I 31 
modified by Pailler-Rodde t al. 1141. 
Oligonwkoride primers used for PCR were synthesized using an 
Applied Biosystem Model 3SlA DNA synthesizer. The position and 
sequence of the different primers are summarized in Table I. The 
position of the primers for c-erb-A and ,9-actin mRNAs was chosen 
according to Mitsuhashi et al. [15], Nude1 et al. [16], and Murray et 
al. [ 171. The primers for RAR mRNA were chosen by comy+ring the 
murine RAR-p sequence with those of human and chicken, and of 
murine RAR-a and -y. These positions were prepared according to 
the sequence published [I S-201. 
Prepnrurion of cDNA was carried out as described by Pailler-Rodde 
et al. [14]. 
Synthesized cDNA (I5 ~1) was amplified by the polymerase chain 
reaction (PCR) using ?uq p;iymerase [‘ii. Tne amplification was 
performed according to Pailler-Rodde et al. [l4]. The reaction was 
carried out for a total of 34 cycles. 
For quantltutil*r o talysis o~PCRprohrcrs, lObI of ihe PCR reaction 
were sampled afier each (from the 11 th to 27th) amplification cycle 
and then at the lust cycle [22], and the co-amplified fragments were 
separated by clectrophoreais ona 10% acrylamide gel. The incorpo- 
rated radioactivity was visualized by autoradiogr;iphy, and the bands 
were excised from the gels and quantiflcd by scintillation counting. 
3. RESULTS 
Results are summarized in Table II. 
3.1. Hormone &if&g 
After T, treatment (3 injections of 50 yg/lOO g b.wt. 
in 60 h) the capacity (C,,,) of TR in liver was increased 
by 68% relative to the control value. The administration 
of a single dose of RA (500 ,uM8/100 g) by gastric intuba- 
tion simultaneously with the last T3 injection induced, 
12 h after administration, a decrease in C,,, of TR by 
22% relative to the Tj treatment value. 
There was no significant effect on liver C,,, of RAR 
in rats treated with T, alone compared to control ani- 
mals. In contrast, the combination of T3 and RA in- 
duced a decrease in C mnx of RAR of 24% relative to the 
control value. 
3.2. mRNA abundance 
The abundance of c-erb-A mRNAs in the liver de- 
creased by 51% relative to the control value in rats 
treated with T3 alone, and by 77% in rats treated with 
T3 and RA. 1x1 contrast he abundance of RAR mRNA 
was strongly increased by both treatments: the levels 
were increased approximately fourfold after T3 treat- 
ment alone, and by twofold after T3 and RA in combi- 
nation. 
In the present investigation only the mRNAs coding 
for proteins which bind TJ, i.e. c-erb-A a mRNA and 
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Fig. I. Size-exclusion chromatography analysis of a nuclear extract 
incubated with a saturated conceniration of [‘Hlretinoic acid. 
(A) Ultraviolet (280 nm) standard profile: (I) human albumin, (2) egg 
albumin, (3) horse myoglobin. (U) [‘HlRctinoicacid bound to proteins 
in ihe absence (0, total binding) or in the presence of 100,uM unlabeled 
retinoic acid (0, non-specific binding):). 
c-erb-A B mRNA, have been quantified. These mea- 
surements have facilitated a comparison of the content 
of c-erb-A mRNAs with nuclear binding capacity as 
determined by isotopic displacement analysis. 
It was observed that the administration of TJ induced 
an increase in the C,,,, of TR associated with an increase 
in cytosolic malate dehydrogenase activity, an enzyme 
that is T3 dependent (data not shown). Such a result is 
consistent with previous studies showing an increase in 
C,,,, of TR correlating with an increase in mitochon- 
drinl a-glycerophosphate dehydrogenase activity (an- 
other T, dependent enzyme) in T,-treated rats 123,241. 
Tl?ese resl~!ts di_‘fer from_ +.hos~ nht+aind with rmri0lJs ” WY.I..._.. ** ..I. . ..I. 
cell lines showing a time- and dose-dependent down- 
regulation of TR by T3 [Z-27]. To explain such a dis- 
crepancy between results obtained with either cell lines 
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Table I 
Synthesized primers used for PCR 
September 1992 
Primers Scqucnce (5’3’) 
/3-Actin” Al AGGATGCAGAAGGAGATTACTGCC 
A2 GTAAAACGCAGCTCAGTAACAGTCC 
c-erb-A” El TCCTGATGAAGGTGACGGACCTGC 
E2 TCAAAGACTTCCAAGAAGAGAGGC 
RAR’ Rl CTCACTGAGAAGATCCGGAAAGCCCACC 
R2 TTGGTGGCCAGCTCACTGAA’l-fTGTCCC 
“From rat cytoplasmic8-actin according to the sequence of Nude1 et al. [16]. 
bFrom rat c-e&~-A cDNA according to the sequence of Murray et al. [ll. 
‘From murine RAR cDNA according to the sequence of Zelcnt et al. [18]. 
Complcmentitry siles 
2,814-2,837 
3.159-3.135 
1,247-1,270 
1,36+1.341 
538-565 
680-653 
or intact animals it is suggested that T3 administration 
in intact animals induces various biochemical events 
occurring at a post-transcriptional level, which are then 
able to modify the properties of the nuclear Tj reccp- 
tar. 
Under the conditions used in our experiments, i.e. 
when measurements were performed 60 h after Tj ad- 
ministration, the c-erb-A mRNA levels were decreased. 
Previous studies designed to assess the effect of the thy- 
roidal state on the c-erb-A mRNA levels have yielded 
conflicting results, Our results are in agreement with 
those obtained on cell lines [28,29], but only partially 
consistent with those obtained in intact rats [30]. Indeed 
in this study Tj reduces the amount of c-erb-A tc mRNA 
by approximately 50% but has no effect on the c-erb-A 
p mRNA levels, while in control rats the level of c-erb-A 
B mRNA is approximately fourfold that of the c-erb-A 
a mRNA. The discrepancy observed between the level 
of TR and the level oft-erb-A mRNAs could be related 
to the time shift observed between a change in the level 
of the c-erb-A mRNAs and the change in the T, binding 
activity [3 11. 
4.2. Effects of RA on c-erb-A rnRNAs and mclear T3 
receptors in T,-treated rats 
The effect of the RA administration on C,,, of TR 
was related to the T3 status of the rats: the C,,, was 
increased relative to euthyroid rats but decreased rela- 
tive to hyperthyroidic rats. So RA down-modulated the 
effect of TJ on TR. 
The decrease of c-erb-A mRNAs levels induced by 
RA and T,-treated rats was more extensive than the 
decrease shown in only T,-treated rats. So RA and T1 
act synergistically to down-modulate the c-erb-A 
mRNA level. 
In hyperthyroidic rats the effect of RA on the C,, of 
TR is consistent with its effect on mRNA, and induces 
a decrease in TJ binding. Such an effect has been shown 
in a mouse prc-adipocyte cell line in which R.A decreases 
c-erb-A expression [29]. Moreover, in intact rats it was 
known that a retinol-overloaded diet induces decreases 
in c-erb-A mRNA levels and in the C,, of TR [14]. 
4.3. Effecrs of T3 on RAR t&WA atrd RAR 
There is some evidence for heteroregulation f super- 
family receptors by ligands that are not their own, but 
results concerning the effect of Ta are scarce [32] and 
none have been concerned with the effect on RAR. Our 
study showing elevated RAR mRNA levels after T3 
administration i dicated the modulation of the messen- 
ger by T3. It does not, however, allow the determination 
of whether this change is caused by a direct action on 
the RAR gene, mRNA processing, or mRNA stabiliza- 
tion. This increase of mRNAs is not consistent with an 
Table II 
Cnpacity of T, and RA nuclear eceptor and proportion of c-erb-A and RAR mRNA to jkrctin mRNA 
c-crb-A RAR 
C;lpncity’ (pmoUmg pro0 mRNAb t&~.‘&,) Capacity lpmobmg prot) mRNA (rlRAH/Ati) 
Control 0.3 16 C 0.022 0.35 4.46 2 0.048 0.04 
Hyper T3 0.531 f 0.018 0.17 4.30 +, 0.0053 0.15 
Hyper T, -I- AR 0.4i6 f 0.022 0.08 2 g: f t?.O!? * _ 999 
(C,J values were obtained by Scatcbrtrd analysis. 
“Each value is the mean ? S.E.M. of 8 animals; PcO.05 compared with controls (Studem’s r-test). 
“Each value represents he mean of 4 separate mcasuremcnts; ArbA. /lRAk and A,, are absolute values of c-crb-A. RAR and /I-actin mRNA. 
respectively. 
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Fig. 2. Saturation bindingcurves of(A) [‘Jl]triiodothyroninc obtained 
with c-crb-A and (B) [‘Hlretinoic acid obtained with rctinoic acid 
nuclear eceptor. Hepatic nuclear fractions were obtained from con- 
trol (v), hypcrthyroidic (m), and hyprthyroidic + retinoic acid (0) 
rats. 
unchanged C,, of RAR. The mechanism involved in 
such a phenomenon is not known, but, as previously 
noted, a time shift between both phenomena has been 
implicated. 
4.4. Effects of RA on RAR mRNA and RAR in T,- 
treated rats 
It has been shown that RA up-regulates the RARq9, 
which is the major isoform of RAR in liver [33], and 
RAR-b mRNA [3], but the effect of RA in rats pre- 
treated with T3 was not known. This study provides 
evidence for an attenuation of the T,-induced increase 
of RAR mRNA levels by RA. This attenuation of T, 
action concerned both RAR mRNA and RAR. So it is 
clear that when the RAR mRNAs level has been exper- 
I 1 I _I 
10 15 20 25 
n 
Fig. 3. Kinetic analysis of PCR products from @actin, c-u-b-A and 
RAR mRNAs. (A) Auloradiogram of acrylamide gel electrophoresis 
of PCR co-umplified products of rot transcripts of the/?-actin (222 bp), 
c-erb-A (1 I8 bp), and RAR (143 bp) genes. (B) Semi-logarithmic 
representation of the relative extent of amplification in control rats 
measured by counting the amount of lzP incorporated into the Trap- 
ments’visualizcd in A; n is the number of PCR cycles; y is the incorpo- 
rated radioactivity (cpm); (0) /?-actin; (0) retinoic acid receptor; (0) 
c-erb-A. 
imentally increased RA is able to down-regulate the 
mRNA levels. 
In summary, these results have established that in 
hyperlhyroidic rats the administration of RA induced 
an attenuation of C,,, of TR and c-erb-A rnRNA and 
of Cm,,, of RAR and RAR mRNA. Future studies are 
needed to explore the mechanisms involved in the mod- 
ulation of these receptors and in particular in the 
heterologous regulation of TR by RA. Such data are 
interesting because they can contribute to an under- 
standing of how an excess of vitamin A has an inhib- 
itory effect on thyroid function. It has been known for 
a long time that there is an amelioration of symptoms 
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in hyperthyroidic patients treated with large doses of 
retinol[34], and that vitamin A treatment decreased the 
severity of experimental thyroiditis in guinea pigs and 
rats [35]. Various mechanisms are suspected to account 
for these observations ince vitamin A modifies thyroid 
hormone functions at multiple sites, including cellular 
uptake of T3 [36] and peripheral metabolism of thyroid 
hormones [37]. Recently it was shown that retinol was 
an inhibitor of TSM-stimulated iodine metabolism [38]. 
Our results showed that it is also possible that the be- 
nefit of the vitamin A treatment is the result of a down- 
heteroregulation of TR by RA, the active metabolite of 
retinal. 
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